CoChat

Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells

Open access

Published version of a preprint

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Abstract

We explored human induced pluripotent stem cells (hiPSCs) derived from different tissues to gain insights into genomic integrity at single-nucleotide resolution. We used genome sequencing data from two large hiPSC repositories involving 696 hiPSCs and daughter subclones. We find ultraviolet light (UV)-related damage in ~72% of skin fibroblast-derived hiPSCs (F-hiPSCs), occasionally resulting in substantial mutagenesis (up to 15 mutations per megabase). We demonstrate remarkable genomic heterogeneity between independent F-hiPSC clones derived during the same round of reprogramming due to oligoclonal fibroblast populations. In contrast, blood-derived hiPSCs (B-hiPSCs) had fewer mutations and no UV damage but a high prevalence of acquired BCOR mutations (26.9% of lines). We reveal strong selection pressure for BCOR mutations in F-hiPSCs and B-hiPSCs and provide evidence that they arise in vitro. Directed differentiation of hiPSCs and RNA sequencing showed that BCOR mutations have functional consequences. Our work strongly suggests that detailed nucleotide-resolution characterization is essential before using hiPSCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-022-01147-3

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Comparison of mutation burden in EPC-derived and F-hiPSCs. a, Source of hiPSCs. Multiple hiPSC lines created from patient S2 contrasted to fibroblast- and EPC-derived hiPSCs created from ten other individuals. b, Mutation burden of substitutions, double substitutions (first row), substitution types (second row), skin-derived signatures (third row), indel types (fourth row) and rearrangements (lowest row). Supplementary Table 2 provides source information. UV-specific features, such as elevated CC>TT double substitutions and UV mutational signatures, were enriched in F-hiPSCs.
Fig. 1 Comparison of mutation burden in EPC-derived and F-hiPSCs. a, Source of hiPSCs. Multiple hiPSC lines created from patient S2 contrasted to fibroblast- and EPC-derived hiPSCs created from ten other individuals. b, Mutation burden of substitutions, double substitutions (first row), substitution types (second row), skin-derived signatures (third row), indel types (fourth row) and rearrangements (lowest row). Supplementary Table 2 provides source information. UV-specific features, such as elevated CC>TT double substitutions and UV mutational signatures, were enriched in F-hiPSCs.CC BY · PubMed Central
Fig. 2 Mutation burden and mutational signatures in F-hiPSCs. a, Summary of HipSci F-hiPSC dataset. A total of 452 F-hiPSCs were generated from 288 healthy donors. A total of 324 hiPSCs were whole-genome sequenced (coverage, 41×), 381 were whole-exome sequenced (coverage, 72×), and 106 had their matched fibroblasts whole-exome sequenced with high-coverage (hcWES) (coverage, 271×). Supplementary Table 3 provides source information. Numbers within black circles denote the number of F-hiPSCs that had data from multiple sequencing experiments. b, Mutation burden of substitutions (subs), CC>TT double substitutions and indels in F-hiPSCs from WGS. Data summary is provided in Supplementary Table 4. Black dots and error represent mean ± standard deviation of hiPSC observations, n = 324 WGS of hiPSCs. c, Distribution of mutational signatures in 324 F-hiPSC lines. The inset figure shows the relative exposures of mutational signatures types. d, Relationships between mutation burdens of CC>TT double substitutions and UV-caused mutation burden of substitutions in F-hiPSCs, n = 324 WGS of hiPSCs. e,f, Histograms of aggregated mutation burden on transcribed (red) and nontranscribed (cyan) strands for C>T (e) and CC>TT (f), n = 324 WGS of hiPSCs. Transcriptional strand asymmetry across replication timing regions was observed. g,h, Distribution of substitution burden of F-hiPSCs with respect to donor’s age (g) and gender (h).
Fig. 2 Mutation burden and mutational signatures in F-hiPSCs. a, Summary of HipSci F-hiPSC dataset. A total of 452 F-hiPSCs were generated from 288 healthy donors. A total of 324 hiPSCs were whole-genome sequenced (coverage, 41×), 381 were whole-exome sequenced (coverage, 72×), and 106 had their matched fibroblasts whole-exome sequenced with high-coverage (hcWES) (coverage, 271×). Supplementary Table 3 provides source information. Numbers within black circles denote the number of F-hiPSCs that had data from multiple sequencing experiments. b, Mutation burden of substitutions (subs), CC>TT double substitutions and indels in F-hiPSCs from WGS. Data summary is provided in Supplementary Table 4. Black dots and error represent mean ± standard deviation of hiPSC observations, n = 324 WGS of hiPSCs. c, Distribution of mutational signatures in 324 F-hiPSC lines. The inset figure shows the relative exposures of mutational signatures types. d, Relationships between mutation burdens of CC>TT double substitutions and UV-caused mutation burden of substitutions in F-hiPSCs, n = 324 WGS of hiPSCs. e,f, Histograms of aggregated mutation burden on transcribed (red) and nontranscribed (cyan) strands for C>T (e) and CC>TT (f), n = 324 WGS of hiPSCs. Transcriptional strand asymmetry across replication timing regions was observed. g,h, Distribution of substitution burden of F-hiPSCs with respect to donor’s age (g) and gender (h).CC BY · PubMed Central
Fig. 3 Genomic heterogeneity in F-hiPSCs. a, Comparison of substitutions carried by pairs of hiPSCs that were derived from fibroblasts of the same donor and in the same reprogramming experiment. Each circle represents a single donor. Hollow circles indicate that two hiPSCs from the same donor share fewer than ten mutations, whereas filled circles indicate that they share ten or more mutations. Colors denote cosine similarity values between mutation profiles of two hiPSCs. A very high score (purple hues) indicates a strong likeness. n = 164 fibroblasts with two derived hiPSCs. b, Correlations between number of mutations in hiPSCs and their matched fibroblasts, n = 324 WGS of hiPSCs. c, Summary of subclonal clusters in fibroblasts (n = 204 WGS of fibroblasts) and hiPSCs (n = 324 WGS of hiPSCs). Kernel density estimation was used to smooth the distribution. Local maximums and minimums were calculated to identify subclonal clusters. Each dot represents a cluster that has at least 10% of total mutations in the sample. Most fibroblasts are polyclonal with a cluster VAF near 0.25, whereas hiPSCs are mostly clonal, with VAF near 0.5. d, Schematic illustration of genomic heterogeneity in F-hiPSCs. Through bulk sequencing of fibroblasts, all of these cells will carry all the mutations that were present in the gray cell, their most recent common ancestor. The individual cells will also carry their unique mutations depending on the DNA damage received by each cell. Each hiPSC clone is derived from a single cell. Subclone 1 and subclone 2 cells are more closely related and could share a lot of mutations in common, because they share a more recent common ancestor. However, they are distinct cells and will create separate hiPSC clones. Subclone 6 (orange cells) and subclone 12 (red cells) are not closely related to the green cells and have received more DNA damage from UV, making them genomically divergent from the green cells. They could still share some mutations in common, because they shared a common ancestor at some early point, but will have many of their own unique mutations (largely due to UV damage).
Fig. 3 Genomic heterogeneity in F-hiPSCs. a, Comparison of substitutions carried by pairs of hiPSCs that were derived from fibroblasts of the same donor and in the same reprogramming experiment. Each circle represents a single donor. Hollow circles indicate that two hiPSCs from the same donor share fewer than ten mutations, whereas filled circles indicate that they share ten or more mutations. Colors denote cosine similarity values between mutation profiles of two hiPSCs. A very high score (purple hues) indicates a strong likeness. n = 164 fibroblasts with two derived hiPSCs. b, Correlations between number of mutations in hiPSCs and their matched fibroblasts, n = 324 WGS of hiPSCs. c, Summary of subclonal clusters in fibroblasts (n = 204 WGS of fibroblasts) and hiPSCs (n = 324 WGS of hiPSCs). Kernel density estimation was used to smooth the distribution. Local maximums and minimums were calculated to identify subclonal clusters. Each dot represents a cluster that has at least 10% of total mutations in the sample. Most fibroblasts are polyclonal with a cluster VAF near 0.25, whereas hiPSCs are mostly clonal, with VAF near 0.5. d, Schematic illustration of genomic heterogeneity in F-hiPSCs. Through bulk sequencing of fibroblasts, all of these cells will carry all the mutations that were present in the gray cell, their most recent common ancestor. The individual cells will also carry their unique mutations depending on the DNA damage received by each cell. Each hiPSC clone is derived from a single cell. Subclone 1 and subclone 2 cells are more closely related and could share a lot of mutations in common, because they share a more recent common ancestor. However, they are distinct cells and will create separate hiPSC clones. Subclone 6 (orange cells) and subclone 12 (red cells) are not closely related to the green cells and have received more DNA damage from UV, making them genomically divergent from the green cells. They could still share some mutations in common, because they shared a common ancestor at some early point, but will have many of their own unique mutations (largely due to UV damage).CC BY · PubMed Central
Fig. 4 Selection analysis revealed positive selective forces on BCOR mutations in F-hiPSCs and B-hiPSCs. a, Driver discovery workflow. Each BCOR mutation was curated using a genome browser. b, Number of reads reporting BCOR mutations in 11 F-hiPSCs and their founding fibroblasts. Colors are indicative of whether the sequencing read contains a mutation or otherwise (green, reads with reference (REF) allele; orange, reads with alternate (ALT) allele). c, BCOR mutation status of Insignia B-hiPSCs. Not shown are 50 of 78 B-hiPSCs that do not carry any BCOR variants in parental hiPSCs or their corresponding subclones. Rows indicate B-hiPSCs derived from various donors, including patients with genetic defects and healthy controls. Columns indicate parental hiPSC (iPSC) and daughter subclones (s1–s4). BCOR mutation status is shown in brown if at least one read contains a BCOR mutation in the sample or blue if there are no reads containing BCOR mutations in that sample. Gray indicates that a sample was not available (N/A). Total count of substitutions and indels of each iPSC is shown in histogram on the right. d, Schematic illustration of positions of mutations in BCOR protein in all F-hiPSCs (blue) and B-hiPSCs (purple). e, Exploring relationship between hiPSC mutation burden and BCOR status (two-sided Mann–Whitney test). hiPSCs with BCOR hits are highlighted with a darker shade of purple (B-hiPSCs) and blue (F-hiPSCs). MT, mutant; WT, wild-type.
Fig. 4 Selection analysis revealed positive selective forces on BCOR mutations in F-hiPSCs and B-hiPSCs. a, Driver discovery workflow. Each BCOR mutation was curated using a genome browser. b, Number of reads reporting BCOR mutations in 11 F-hiPSCs and their founding fibroblasts. Colors are indicative of whether the sequencing read contains a mutation or otherwise (green, reads with reference (REF) allele; orange, reads with alternate (ALT) allele). c, BCOR mutation status of Insignia B-hiPSCs. Not shown are 50 of 78 B-hiPSCs that do not carry any BCOR variants in parental hiPSCs or their corresponding subclones. Rows indicate B-hiPSCs derived from various donors, including patients with genetic defects and healthy controls. Columns indicate parental hiPSC (iPSC) and daughter subclones (s1–s4). BCOR mutation status is shown in brown if at least one read contains a BCOR mutation in the sample or blue if there are no reads containing BCOR mutations in that sample. Gray indicates that a sample was not available (N/A). Total count of substitutions and indels of each iPSC is shown in histogram on the right. d, Schematic illustration of positions of mutations in BCOR protein in all F-hiPSCs (blue) and B-hiPSCs (purple). e, Exploring relationship between hiPSC mutation burden and BCOR status (two-sided Mann–Whitney test). hiPSCs with BCOR hits are highlighted with a darker shade of purple (B-hiPSCs) and blue (F-hiPSCs). MT, mutant; WT, wild-type.CC BY · PubMed Central
Fig. 5 Functional validation of the impact of BCOR mutations in hiPSCs and their differentiation potential. a, PC analysis showing hiPSCs distribution based on their transcriptome expression. Transcriptomics changes are correlated with BCOR mutation VAF values. 0* denotes that no BCOR mutations were found in hiPSC parental lines but were seen in their subclones. b, Volcano plot of differential gene expression analysis in hiPSCs with BCOR mutations (BCOR-mut) and no BCOR mutations (BCOR-wt) lines. FC, fold change. c, Heatmap of relative expression levels of members of noncanonical polycomb repressive complex 1.1 (PRC1.1), hiPSCs pluripotency and the three germ layers markers for two BCOR-wt (blue: MSH34i2, MSH30i3) and two BCOR-mut (orange: MSH40i2, MSH93i6) hiPSC lines. d, Immunofluorescence characterization of hiPSCs, neural stem cells (NSCs) and neurons at day 0, day 12 and day 27, respectively. Both BCOR-mut and BCOR-wt hiPSCs have similar undifferentiated morphology and express pluripotency markers OCT4/POU5F1 (red) and SSEA4 (green). BCOR-mut lines undergo inefficient neural induction, as highlighted by a reduced number of NSCs expressing PAX6 (green) at day 12 and a reduced number of neurons marked by TUBB3 (green) at day 27.
Fig. 5 Functional validation of the impact of BCOR mutations in hiPSCs and their differentiation potential. a, PC analysis showing hiPSCs distribution based on their transcriptome expression. Transcriptomics changes are correlated with BCOR mutation VAF values. 0* denotes that no BCOR mutations were found in hiPSC parental lines but were seen in their subclones. b, Volcano plot of differential gene expression analysis in hiPSCs with BCOR mutations (BCOR-mut) and no BCOR mutations (BCOR-wt) lines. FC, fold change. c, Heatmap of relative expression levels of members of noncanonical polycomb repressive complex 1.1 (PRC1.1), hiPSCs pluripotency and the three germ layers markers for two BCOR-wt (blue: MSH34i2, MSH30i3) and two BCOR-mut (orange: MSH40i2, MSH93i6) hiPSC lines. d, Immunofluorescence characterization of hiPSCs, neural stem cells (NSCs) and neurons at day 0, day 12 and day 27, respectively. Both BCOR-mut and BCOR-wt hiPSCs have similar undifferentiated morphology and express pluripotency markers OCT4/POU5F1 (red) and SSEA4 (green). BCOR-mut lines undergo inefficient neural induction, as highlighted by a reduced number of NSCs expressing PAX6 (green) at day 12 and a reduced number of neurons marked by TUBB3 (green) at day 27.CC BY · PubMed Central
Fig. 6 Culture-associated mutagenesis in hiPSCs. a, Mutations in F-hiPSCs were separated into two groups: (1) mutations shared between F-hiPSCs and their founding fibroblasts (left) and (2) mutations that are private to hiPSCs (right). Proportional graphs show substitution signatures of shared and private mutations. Culture-related signature (signature 18) is enriched in private mutations. b, Box plot of exposures of substitution signatures of shared (blue) and private (orange) mutations. Culture signatures (signature 18) account for ~50% of private substitutions, in contrast to nearly zero among shared mutations. Box plots denote median (horizontal line) and 25th to 75th percentiles (boxes). The lower (minima) and upper (maxima) whiskers extend to 1.5× the interquartile range. n = 324 WGS of hiPSCs. c, Number of samples carrying each signature within shared or private mutations. Most samples acquired the culture signature late in the hiPSC cloning process. d, Relationship between exposure of culture-related signature (signature 18) and passage number (Pearson’s correlation test, two sided). e, Schematic illustration of the mutational processes in fibroblasts and F-hiPSCs.
Fig. 6 Culture-associated mutagenesis in hiPSCs. a, Mutations in F-hiPSCs were separated into two groups: (1) mutations shared between F-hiPSCs and their founding fibroblasts (left) and (2) mutations that are private to hiPSCs (right). Proportional graphs show substitution signatures of shared and private mutations. Culture-related signature (signature 18) is enriched in private mutations. b, Box plot of exposures of substitution signatures of shared (blue) and private (orange) mutations. Culture signatures (signature 18) account for ~50% of private substitutions, in contrast to nearly zero among shared mutations. Box plots denote median (horizontal line) and 25th to 75th percentiles (boxes). The lower (minima) and upper (maxima) whiskers extend to 1.5× the interquartile range. n = 324 WGS of hiPSCs. c, Number of samples carrying each signature within shared or private mutations. Most samples acquired the culture signature late in the hiPSC cloning process. d, Relationship between exposure of culture-related signature (signature 18) and passage number (Pearson’s correlation test, two sided). e, Schematic illustration of the mutational processes in fibroblasts and F-hiPSCs.CC BY · PubMed Central
Extended Data Fig. 1 Mutational signatures of hiPSCs. Mutational profiles of 18 blood-derived human induced pluripotent stem cells (hiPSCs) and skin-derived hiPSCs featured in Fig. 1.
Extended Data Fig. 1 Mutational signatures of hiPSCs. Mutational profiles of 18 blood-derived human induced pluripotent stem cells (hiPSCs) and skin-derived hiPSCs featured in Fig. 1.CC BY · PubMed Central
Extended Data Fig. 2 Distribution of passage number of HipSci F-hiPSCs. The median is 18. n = 288 fibroblasts. Passage (P) numbers of eight non-HipSci hiPSCs are: P2 for: S7_RE11, S7_RE14, S7_RE2, S7_RE17, S2_RE19, S2_SF3 and S2_SF2; P1 for S2_RE5.
Extended Data Fig. 2 Distribution of passage number of HipSci F-hiPSCs. The median is 18. n = 288 fibroblasts. Passage (P) numbers of eight non-HipSci hiPSCs are: P2 for: S7_RE11, S7_RE14, S7_RE2, S7_RE17, S2_RE19, S2_SF3 and S2_SF2; P1 for S2_RE5.CC BY · PubMed Central
Extended Data Fig. 3 HipSci F-hiPSC mutational signatures. A, Distribution of mutational signatures in 324 fibroblast-derived iPSC lines. The inset figure shows the relative exposures of mutational signatures/indel types. B, Correlation between substitution signatures and indel types (Pearson’s correlation test, two-sided).
Extended Data Fig. 3 HipSci F-hiPSC mutational signatures. A, Distribution of mutational signatures in 324 fibroblast-derived iPSC lines. The inset figure shows the relative exposures of mutational signatures/indel types. B, Correlation between substitution signatures and indel types (Pearson’s correlation test, two-sided).CC BY · PubMed Central
Extended Data Fig. 4 Mutation burden and mutational signatures in fibroblasts. A, Mutation burden of substitutions, CC>TT double substitutions and indels in fibroblasts. Black dots and error bars represent mean ± SD of fibroblast observations, n = 204 Whole Genome Sequencing (WGS) of fibroblasts. B, The amount of each mutational signature and indel type (exposure) in fibroblasts.
Extended Data Fig. 4 Mutation burden and mutational signatures in fibroblasts. A, Mutation burden of substitutions, CC>TT double substitutions and indels in fibroblasts. Black dots and error bars represent mean ± SD of fibroblast observations, n = 204 Whole Genome Sequencing (WGS) of fibroblasts. B, The amount of each mutational signature and indel type (exposure) in fibroblasts.CC BY · PubMed Central
Extended Data Fig. 5 Analysis of Variant Allele Frequency in fibroblasts and iPSCs. Distribution of Variant Allele Frequency (VAF) distribution of five fibroblasts and five hiPSCs are shown in (A) and (B), respectively. Kernel density estimation was used to smooth the distribution. Local maximums and minimums were calculated to identify subclonal clusters. C, Summary of subclonal clusters in fibroblasts (n = 204) and hiPSCs (n = 324). Each dot represents a cluster which has at least 10% of total mutations in the sample. Most of the fibroblasts are polyclonal with VAF of a cluster of nearly 0.25, whereas hiPSCs are mostly clonal with VAF of nearly 0.5.
Extended Data Fig. 5 Analysis of Variant Allele Frequency in fibroblasts and iPSCs. Distribution of Variant Allele Frequency (VAF) distribution of five fibroblasts and five hiPSCs are shown in (A) and (B), respectively. Kernel density estimation was used to smooth the distribution. Local maximums and minimums were calculated to identify subclonal clusters. C, Summary of subclonal clusters in fibroblasts (n = 204) and hiPSCs (n = 324). Each dot represents a cluster which has at least 10% of total mutations in the sample. Most of the fibroblasts are polyclonal with VAF of a cluster of nearly 0.25, whereas hiPSCs are mostly clonal with VAF of nearly 0.5.CC BY · PubMed Central
Extended Data Fig. 6 Shared mutations. Histogram showing shared mutations between hiPSCs and the matched fibroblasts.
Extended Data Fig. 6 Shared mutations. Histogram showing shared mutations between hiPSCs and the matched fibroblasts.CC BY · PubMed Central
Extended Data Fig. 7 Mutational signatures of shared mutations. Mutation profile of substitutions that were removed from hiPSCs by using fibroblast as ‘normal’ for ten HipSci samples from Fig. 1. These removed mutations are not germline Single Nucleotide Polymorphisms (SNPs), and are mostly composed of mutations that are typical of ultraviolet (UV) light exposure.
Extended Data Fig. 7 Mutational signatures of shared mutations. Mutation profile of substitutions that were removed from hiPSCs by using fibroblast as ‘normal’ for ten HipSci samples from Fig. 1. These removed mutations are not germline Single Nucleotide Polymorphisms (SNPs), and are mostly composed of mutations that are typical of ultraviolet (UV) light exposure.CC BY · PubMed Central
Extended Data Fig. 8 Comparison of WES (72X) and high-coverage WES (hcWES, 271X) of fibroblasts. More mutations in hiPSCs were discovered in fibroblasts (shared mutations) through high-coverage Whole Exome Sequencing (hcWES) than through WES, resulting in the percentage of shared mutations increased in hcWES data. Interestingly, the mutational profile of these increased shared mutations is very similar to the UV signature, indicating that increasing sequencing depth enables more UV-caused somatic mutations that were found in hiPSCs to also be detected in the corresponding fibroblasts.
Extended Data Fig. 8 Comparison of WES (72X) and high-coverage WES (hcWES, 271X) of fibroblasts. More mutations in hiPSCs were discovered in fibroblasts (shared mutations) through high-coverage Whole Exome Sequencing (hcWES) than through WES, resulting in the percentage of shared mutations increased in hcWES data. Interestingly, the mutational profile of these increased shared mutations is very similar to the UV signature, indicating that increasing sequencing depth enables more UV-caused somatic mutations that were found in hiPSCs to also be detected in the corresponding fibroblasts.CC BY · PubMed Central
Extended Data Fig. 9 Brightfield images showing cell morphology changes during neural differentiation stages. HiPSCs with BCOR mutations (BCOR-mut) samples have normal hiPSC colony morphology (Day 0). The differentiation of cells into neurons (Day 27) showed fewer differentiated cells in BCOR-mut compared to hiPSCs with no BCOR mutations (BCOR-wt).
Extended Data Fig. 9 Brightfield images showing cell morphology changes during neural differentiation stages. HiPSCs with BCOR mutations (BCOR-mut) samples have normal hiPSC colony morphology (Day 0). The differentiation of cells into neurons (Day 27) showed fewer differentiated cells in BCOR-mut compared to hiPSCs with no BCOR mutations (BCOR-wt).CC BY · PubMed Central
Extended Data Fig. 10 Immunofluorescence characterization of BCOR-mut and BCOR-wt at different neural differentiation stages. a, At the hiPSC stage, BCOR-mut colonies are indistinguishable from BCOR-mut, both expressing SSEA4 (green) and OCT4/POU5F1 (red). b,c, BCOR-mut cells have impaired neural differentiation resulting in fewer Pax 6 positive cells at Day 12 (b) and TUBB3 positive cells at Day 27 (c).
Extended Data Fig. 10 Immunofluorescence characterization of BCOR-mut and BCOR-wt at different neural differentiation stages. a, At the hiPSC stage, BCOR-mut colonies are indistinguishable from BCOR-mut, both expressing SSEA4 (green) and OCT4/POU5F1 (red). b,c, BCOR-mut cells have impaired neural differentiation resulting in fewer Pax 6 positive cells at Day 12 (b) and TUBB3 positive cells at Day 27 (c).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Cited by

See all 105

Metadata

Authors
Rouhani, F. J., Zou, X., Danecek, P., Badja, C., Amarante, T. D., Koh, G., Wu, Q., Memari, Y., Durbin, R., Martincorena, I., Bassett, A. R., Gaffney, D., & Nik-Zainal, S.
Affiliations
  • University of Cambridge (GB)
  • Wellcome Sanger Institute (GB)
Venue
Nature Genetics
Published
2022-08-11
Volume
54
Issue
9
Pages
1406-1416
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W4292870483
Cited by
105
References
87
Citations by year
2026: 24 · 2025: 21 · 2024: 27 · 2023: 23 · 2022: 9
FWCI
6.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Genetics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo
Funders
  • Cancer Research UK (C60100/A23916)
  • Wellcome Trust (WT100183)
  • DH | National Institute for Health Research (MR/R015724/1)
  • Dr Josef Steiner Cancer Research Award 2019, Medical Research Council (MRC) Grant-in-Aid to the MRC Cancer unit, CRUK Pioneer Award
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
human induced pluripotent stem cells, BCOR mutation, fibroblast-derived iPSCs, clonal heterogeneity, somatic selection, genome stability, reprogramming
MeSH terms
Cell Differentiation, Humans, Mutation, Nucleotides, Proto-Oncogene Proteins, Repressor Proteins, Genomics, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. https://app.cochat.ai/papers/10.1038/s41588-022-01147-3
The paper
Rouhani, F. J., Zou, X., Danecek, P., Badja, C., Amarante, T. D., Koh, G., Wu, Q., Memari, Y., Durbin, R., Martincorena, I., Bassett, A. R., Gaffney, D., & Nik-Zainal, S. (2022). Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nature Genetics. https://doi.org/10.1038/s41588-022-01147-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.